Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1135850.RAe3nf6ZAkK_xjFec68CEF1DvW7rS6r_mKtEwx7kRGAdU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1135850.RAe3nf6ZAkK_xjFec68CEF1DvW7rS6r_mKtEwx7kRGAdU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1135850.RAe3nf6ZAkK_xjFec68CEF1DvW7rS6r_mKtEwx7kRGAdU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1135850.RAe3nf6ZAkK_xjFec68CEF1DvW7rS6r_mKtEwx7kRGAdU130_provenance.
- NP1135850.RAe3nf6ZAkK_xjFec68CEF1DvW7rS6r_mKtEwx7kRGAdU130_assertion description "[T-cell therapy is one such area where recent trials using T cells genetically modified to express an antibody-based chimeric antigen receptor (CAR) targeted against the CD19 antigen have demonstrated impressive responses when adoptively transferred to patients with advanced chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1135850.RAe3nf6ZAkK_xjFec68CEF1DvW7rS6r_mKtEwx7kRGAdU130_provenance.
- NP1135850.RAe3nf6ZAkK_xjFec68CEF1DvW7rS6r_mKtEwx7kRGAdU130_assertion evidence source_evidence_literature NP1135850.RAe3nf6ZAkK_xjFec68CEF1DvW7rS6r_mKtEwx7kRGAdU130_provenance.
- NP1135850.RAe3nf6ZAkK_xjFec68CEF1DvW7rS6r_mKtEwx7kRGAdU130_assertion SIO_000772 24329792 NP1135850.RAe3nf6ZAkK_xjFec68CEF1DvW7rS6r_mKtEwx7kRGAdU130_provenance.
- NP1135850.RAe3nf6ZAkK_xjFec68CEF1DvW7rS6r_mKtEwx7kRGAdU130_assertion wasDerivedFrom befree-2016 NP1135850.RAe3nf6ZAkK_xjFec68CEF1DvW7rS6r_mKtEwx7kRGAdU130_provenance.
- NP1135850.RAe3nf6ZAkK_xjFec68CEF1DvW7rS6r_mKtEwx7kRGAdU130_assertion wasGeneratedBy ECO_0000203 NP1135850.RAe3nf6ZAkK_xjFec68CEF1DvW7rS6r_mKtEwx7kRGAdU130_provenance.
- befree-2016 importedOn "2016-02-19" NP1135850.RAe3nf6ZAkK_xjFec68CEF1DvW7rS6r_mKtEwx7kRGAdU130_provenance.